These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Filed by the Registrant
x
|
Filed by a Party other than the Registrant
o
|
|
o
|
Preliminary Proxy Statement
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
Definitive Proxy Statement
|
|
o
|
Definitive Additional Materials
|
|
o
|
Soliciting Material Pursuant to §240.14a-12
|
|
x
|
No fee required.
|
|
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
o
|
Fee paid previously with preliminary materials.
|
|
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
1.
|
to elect two Class I directors
to serve for a three-year term expiring at the 2022 annual meeting of stockholders;
|
|
2.
|
to ratify the appointment of RSM US LLP as the Company’s independent registered public accountants for the fiscal year ending September 30, 2019; and
|
|
3.
|
to transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
|
By Order of the Board of Directors,
|
|
|
Ned N. Fleming, III
|
|
Executive Chairman of the Board of Directors
|
|
Dothan, Alabama
|
|
January 22, 2019
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
the Proxy Statement for our Annual Meeting;
|
|
•
|
a proxy card with a prepaid return envelope; and
|
|
•
|
our Annual Report, which includes our audited financial statements.
|
|
•
|
By Internet
: Go to the website www.proxyvote.com and follow the instructions. You will need the control number included on the enclosed proxy card in order to vote by internet.
|
|
•
|
By Telephone
: Dial toll-free 1-800-690-6903 and follow the recorded instructions. You will need the control number included on the enclosed proxy card in order to vote by telephone.
|
|
•
|
By Mail
: Mark your selections on the enclosed proxy card, date and sign your name exactly as it appears on the proxy card and mail the proxy card in the enclosed pre-paid envelope. Mailed proxy cards must be received no later than March 7, 2019 in order to be counted at the Annual Meeting.
|
|
|
|
Common Stock Beneficially Owned
|
|
|
|
|||||||||
|
|
|
Class A
|
|
Class B
|
|
|
|
|||||||
|
Name of Beneficial Holder
|
|
Shares
|
|
% of Class
|
|
Shares
|
|
% of Class
|
|
% of Total Voting Power†
|
||||
|
5% Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SunTx CPI Expansion Fund, L.P.
(1)
|
|
-
|
|
|
*
|
|
|
18,312,458
|
|
46.4
|
%
|
|
45.0
|
%
|
|
SunTx Fulcrum Fund Prime, L.P.
(1)
|
|
-
|
|
|
*
|
|
|
10,832,128
|
|
27.4
|
%
|
|
26.6
|
%
|
|
SunTx Fulcrum Dutch Investors Prime, L.P.
(1)
|
|
-
|
|
|
*
|
|
|
5,897,486
|
|
14.9
|
%
|
|
14.5
|
%
|
|
Grace, Ltd.
(2)
|
|
-
|
|
|
*
|
|
|
2,500,048
|
|
6.3
|
%
|
|
6.1
|
%
|
|
ArrowMark Colorado Holdings LLC
(3)
|
|
1,306,398
|
|
|
10.9
|
%
|
|
-
|
|
*
|
|
|
*
|
|
|
Empyrean Capital Partners, LP
(4)
|
|
767,428
|
|
|
6.8
|
%
|
|
-
|
|
*
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directors and Named Executive Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ned N. Fleming, III
(5) (6)
|
|
4,000
|
|
|
*
|
|
|
35,042,072
|
|
88.8
|
%
|
|
86.2
|
%
|
|
Craig Jennings
(5)
|
|
-
|
|
|
*
|
|
|
35,042,072
|
|
88.8
|
%
|
|
86.2
|
%
|
|
Mark R. Matteson
(5)
|
|
1,000
|
|
|
*
|
|
|
35,042,072
|
|
88.8
|
%
|
|
86.2
|
%
|
|
Michael H. McKay
|
|
-
|
|
|
*
|
|
|
35,406
|
|
*
|
|
|
*
|
|
|
Stefan L. Shaffer
|
|
-
|
|
|
*
|
|
|
-
|
|
*
|
|
|
*
|
|
|
Charles E. Owens
(7)
|
|
-
|
|
|
*
|
|
|
2,500,048
|
|
6.3
|
%
|
|
6.1
|
%
|
|
R. Alan Palmer
|
|
1,500
|
|
|
*
|
|
|
290,209
|
|
*
|
|
|
*
|
|
|
F. Julius Smith, III
(8)
|
|
-
|
|
|
*
|
|
|
101,052
|
|
*
|
|
|
*
|
|
|
All Directors and Executive Officers as a Group (14 persons)
|
|
37,900
|
|
|
*
|
|
|
38,413,039
|
|
97.2
|
%
|
|
94.3
|
%
|
|
*
|
Represents less than 1%.
|
|
†
|
Represents the voting power with respect to all shares of Class A common stock and Class B common stock outstanding as of the Record Date, voting as a single class.
|
|
(1)
|
SunTx CPI Expansion Fund GP, L.P. (“SunTx Expansion Fund GP”) is the general partner of SunTx Expansion Fund, L.P. (“SunTx Expansion Fund”), and SunTx Capital Partners L.P. (“SunTx Partners GP”) is the general partner of each of SunTx Fulcrum Fund Prime, L.P. (“SunTx Fulcrum Fund”) and SunTx Fulcrum Dutch Investors Prime, L.P. (“SunTx Fulcrum Dutch Fund” and, together with SunTx Expansion Fund and SunTx Fulcrum Fund, the “SunTx Funds”). Each of (i) Mr. Fleming, as the sole stockholder and director of SunTx Capital Management Corp. (“SunTx Capital Management”), (ii) SunTx Capital Management, as the general partner of each of SunTx Expansion Fund GP and SunTx Partners GP, (iii) SunTx Expansion Fund GP, as the general partner of SunTx Expansion Fund, and (iv) SunTx Partners GP, as the general partner of each of SunTx Fulcrum Fund and SunTx Fulcrum Dutch Fund, may be deemed to beneficially own shares held by the SunTx Funds. Additionally, Messrs. Jennings and Matteson, as executive officers of SunTx Capital Management, may be deemed to beneficially own shares held by the SunTx Funds. Each of Messrs. Fleming, Jennings and Matteson, as well as SunTx Capital Management, SunTx Expansion Fund GP and SunTx Partners GP, disclaims any beneficial ownership of such shares except to the extent of any proportionate pecuniary interest therein. The address of each of Messrs. Fleming, Jennings and Matteson, SunTx Management, SunTx Expansion Fund GP, SunTx Partners GP and the SunTx Funds is c/o SunTx Capital Management Corp., 5420 LBJ Freeway, Suite 1000, Dallas, Texas 75240.
|
|
(2)
|
Charles E. Owens, our President and Chief Executive Officer, is the general partner of Grace Ltd. As the general partner of Grace Ltd., Mr. Owens may be deemed to beneficially own shares held by Grace Ltd. The business address of Grace Ltd. is 10 Chateau Place, Dothan, Alabama 36303.
|
|
(3)
|
Beneficial ownership information is as of July 31, 2018, as reported on a Schedule 13G filed by ArrowMark Colorado Holdings LLC on August 10, 2018. The address of the business office of ArrowMark Colorado Holdings LLC is 100 Fillmore Street, Suite 325, Denver, Colorado 80206.
|
|
(4)
|
Beneficial ownership information is as of May 4, 2018, as reported on a Schedule 13G filed by Empyrean Capital Partners, LP on May 11, 2018. Based on the Schedule 13G, 720,999 shares of the reported Class A common stock are owned by Empyrean Capital Overseas Master Fund, Ltd., a Cayman Islands exempted company, and 46,429 shares of the Class A common stock are owned by P EMP Ltd., a British Virgin Islands business company. Each of these entities shares voting and dispositive power with Empyrean Capital Partners, LP, a Delaware limited partnership, which serves as investment manager to each of these entities, and Amos Meron, a United States citizen, who serves as the managing member of Empyrean Capital, LLC, the general partner of Empyrean Capital Partners, LP. The address of the business office of each of these persons and entities is c/o Empyrean Capital Partners, LP, 10250 Constellation Boulevard, Suite 2950, Los Angeles, California 90067.
|
|
(5)
|
Includes shares of Class B common stock held by the SunTx Funds. See footnote 1 above.
|
|
(6)
|
Includes 4,000 shares of Class A common stock owned by Mr. Fleming’s spouse.
|
|
(7)
|
Consists of shares of Class B common stock held by Grace Ltd. See footnote 2 above.
|
|
(8)
|
Includes a non-plan option to purchase 74,592 shares of Class B common stock at an exercise price of $0.04 per share, which was fully vested on the date of grant, March 7, 2017, but is only exercisable upon a change of control of the Company, as defined in the option agreement. This option represents part of the consideration paid in the Company’s acquisition of FSC II, LLC (“FSC”).
|
|
•
|
Class I, consisting of Ned N. Fleming, III and Charles E. Owens, whose terms will expire at the Annual Meeting;
|
|
•
|
Class II, consisting of Craig Jennings and Mark R. Matteson, whose terms will expire at the 2020 annual meeting of stockholders; and
|
|
•
|
Class III, consisting of Michael H. McKay and Stefan L. Shaffer, whose terms will expire at the 2021 annual meeting of stockholders.
|
|
Name
|
|
Age
|
|
Position
|
|
|
Ned N. Fleming, III
(2) (3)
|
|
58
|
|
Executive Chairman of the Board and Director
|
|
|
Charles E. Owens
(3)
|
|
68
|
|
President, Chief Executive Officer and Director
|
|
|
Craig Jennings
|
|
60
|
|
Director
|
|
|
Mark R. Matteson
(1) (2) (3)
|
|
55
|
|
Director
|
|
|
Michael H. McKay
(1)
|
|
57
|
|
Director
|
|
|
Stefan L. Shaffer
(1) (2)
|
|
62
|
|
Director
|
|
|
(1)
|
Member of the Audit Committee
|
||||
|
(2)
|
Member of the Compensation Committee
|
||||
|
(3)
|
Member of the Nominating and Corporate Governance Committee
|
||||
|
Name
|
|
Age
|
|
Position
|
|
R. Alan Palmer
|
|
66
|
|
Executive Vice President and Chief Financial Officer
|
|
Todd K. Andrews
|
|
56
|
|
Chief Accounting Officer
|
|
M. Brett Armstrong
|
|
57
|
|
Senior Vice President
|
|
J. Ryan Brooks
|
|
30
|
|
Senior Vice President, Legal
|
|
Robert P. Flowers
|
|
59
|
|
Senior Vice President
|
|
John L. Harper
|
|
54
|
|
Senior Vice President
|
|
F. Julius Smith, III
|
|
49
|
|
Senior Vice President
|
|
John A. Walker
|
|
62
|
|
Senior Vice President
|
|
•
|
reviewing and discussing with management and our independent registered public accounting firm our annual audited and interim unaudited financial statements and related disclosures to be included in our quarterly earnings releases and periodic reports filed with the SEC;
|
|
•
|
recommending to the Board whether our audited financial statements will be included in our Annual Report on Form 10-K;
|
|
•
|
reviewing and discussing the scope and results of the independent registered public accounting firm’s annual audit and quarterly reviews of our financial statements, and any other matters required to be communicated to the Audit Committee by the independent registered public accounting firm;
|
|
•
|
reviewing and discussing with management, our independent registered public accounting firm and any internal personnel or third parties serving an internal audit function the adequacy and effectiveness of our disclosure controls and procedures, our internal controls and procedures for financial reporting and our risk assessment and risk management policies (including those related to significant business risk exposures, such as data privacy and network security);
|
|
•
|
appointing, compensating, retaining and overseeing the work of our independent registered public accounting firm, including their independence;
|
|
•
|
reviewing and preapproving all audit, review or attest services and permitted non-audit services that may be performed by our independent registered public accounting firm;
|
|
•
|
establishing and maintaining guidelines relating to our hiring of employees and former employees of our independent registered public accounting firm;
|
|
•
|
reviewing and discussing the scope and staffing of our internal audit function, including any difficulties encountered by the internal audit function and restrictions on the scope of its work or access to required information, and reviewing significant internal audit reports and management’s responses;
|
|
•
|
confirming the regular rotation of the audit partners with our independent auditor and considering whether there should be regular rotation of our auditors;
|
|
•
|
preparing an annual Audit Committee report to be included in our proxy statement;
|
|
•
|
reviewing legal and regulatory matters that may have a material impact on our financial statements and reviewing our compliance policies and procedures, including the implementation and effectiveness of our compliance programs;
|
|
•
|
participating in the selection of the Company’s lead audit partner;
|
|
•
|
reviewing the Company’s significant financing transactions and related documentation that may have a material impact on the Company’s ability to borrow to ensure that the Company is able to finance its ongoing and future operations, and evaluating whether to recommend that the Board approve or ratify any such financing transaction;
|
|
•
|
considering all of the relevant facts and circumstances available for related party transactions submitted to the Audit Committee in accordance with our written policy governing related party transactions;
|
|
•
|
establishing and maintaining procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls and auditing matters for the confidential, anonymous submission by our employees of concerns regarding questionable accounting and auditing matters;
|
|
•
|
reviewing and discussing all critical accounting policies and practices to be used, all alternative treatments of financial information within GAAP that have been discussed with management, ramifications of the use of such alternative disclosures and treatments, the treatment preferred by the independent auditor, and other material written communications between the independent auditor and management; and
|
|
•
|
reviewing and recommending to the Board director and officer indemnification and insurance policies and procedures.
|
|
•
|
reviewing and approving annually the corporate goals and objectives relevant to the compensation of our executive officers, evaluating the performance of our executive officers in light of those goals and setting the compensation levels of our executive officers based on such evaluation;
|
|
•
|
reviewing the competitiveness of our compensation programs for executive officers to (i) attract and retain executive officers, (ii) motivate our executive officers to achieve our business objectives, and (iii) align the interests of our executive officers and key employees with the long-term interests of our stockholders;
|
|
•
|
reviewing trends in management compensation, overseeing the development of new compensation plans and, when necessary, revising existing plans;
|
|
•
|
periodically reviewing the compensation paid to non-employee directors through annual retainers and any other cash or equity components of compensation and perquisites, and making recommendations to the Board for any adjustments;
|
|
•
|
reviewing and approving the employment agreements, salaries, bonuses, equity or equity-based awards and severance, termination, indemnification and change in control agreements for all of our executive officers;
|
|
•
|
reviewing and approving compensation packages for new executive officers and termination packages for executive officers as may be suggested by management or the Board;
|
|
•
|
reviewing and approving our policies and procedures with respect to expense accounts and perquisites for our executive officers;
|
|
•
|
reviewing and discussing with the Board and our executive officers plans for executive officer development and corporate succession plans for the Company’s executive officers;
|
|
•
|
reviewing and making recommendations concerning long-term incentive compensation plans, including the use of stock options and other equity-based plans;
|
|
•
|
overseeing our employee benefit plans;
|
|
•
|
reviewing periodic reports from management on matters relating to personnel appointments and practices;
|
|
•
|
reviewing and assessing the Company’s policies and practices for compensating its employees, including its executive officers, as they relate to risk management practices, risk-taking incentives and identified major risk exposures to the Company; and
|
|
•
|
making recommendations concerning policies to mitigate risks arising from compensation policies and practices, including policies providing for the recovery of incentive or equity-based compensation and limiting hedging activities related to the Company’s common stock.
|
|
•
|
reviewing and making recommendations regarding the size, composition and organization of the Board;
|
|
•
|
developing and recommending to the Board specific criteria for the selection of directors;
|
|
•
|
with respect to director nominees, (i) identifying individuals qualified to become members of the Board (consistent with criteria approved by the Board), (ii) reviewing the qualifications of any such person submitted to be considered as a director, and (iii) selecting the director nominees for the annual meeting of stockholders or to fill vacancies on the Board;
|
|
•
|
developing and periodically reassessing policies and procedures with respect to the consideration of any director candidate recommended by stockholders or otherwise;
|
|
•
|
reviewing and making recommendations to the Board with respect to the size, composition and organization of Board committees (other than the Nominating and Corporate Governance Committee);
|
|
•
|
recommending procedures for the effective functioning of the Board;
|
|
•
|
assisting the Board in determining whether individual directors have material relationships with the Company that may interfere with their independence;
|
|
•
|
overseeing the Board’s annual self-evaluation process and reporting annually to the Board with an assessment of the Board’s performance;
|
|
•
|
developing and maintaining an orientation program for new directors and continuing education programs for directors; and
|
|
•
|
reviewing and discussing, as appropriate, with management the Company’s public disclosures and its disclosures to stock exchanges relating to independence, governance and director nomination matters, including in the Company’s proxy statement.
|
|
•
|
the recommending stockholder’s name, number of shares owned, length of period held, proof of ownership and written certification that such recommending stockholder intends to continue to remain a stockholder through the date of the annual meeting with respect to which the candidate is to be nominated;
|
|
•
|
the candidate’s name, address, phone number, e-mail address and age;
|
|
•
|
a resume describing, at a minimum, the candidate’s educational background, occupation, employment history and material outside commitments (e.g., memberships on other boards and committees, charitable foundations, etc.);
|
|
•
|
a supporting statement that describes the stockholder’s and candidate’s reasons for nomination to the Board and demonstrates the candidate’s ability to satisfy the director qualifications described above;
|
|
•
|
the candidate’s consent to a background investigation;
|
|
•
|
a notarized affidavit executed by the candidate to the effect that, if nominated and elected, he or she will serve, is eligible for election as a member of the Board, and consents to being named in the proxy statement as a nominee, if he or she will in fact be so named;
|
|
•
|
a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings during the past three years between the nominating stockholder and the candidate;
|
|
•
|
a description of any voting commitments and/or any other arrangements or obligations by which the candidate is or will be bound as a director;
|
|
•
|
a completed questionnaire regarding the candidate, which may be obtained from the Secretary of the Company, relating to the stock exchange listing requirements for director independence that are applicable to the Company; and
|
|
•
|
any other information relating to the recommended stockholder and the candidate that would be required to be disclosed in a proxy statement on Schedule 14A for solicitation of proxies for election of directors under the Exchange Act and pursuant to Nasdaq rules and any other applicable laws, rules or regulations.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Bonus
($)
(1)
|
|
Stock
Awards
($)
(2)
|
|
Option
Awards
($)
(3)
|
|
All
Other
Compensation
($)
(4)
|
|
Total
($)
|
|
Charles E. Owens
|
|
2018
|
|
450,000
|
|
1,074,000
|
|
-
|
|
-
|
|
33,041
|
|
1,557,041
|
|
President and Chief Executive Officer
|
|
2017
|
|
450,000
|
|
715,000
|
|
-
|
|
-
|
|
22,244
|
|
1,187,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R. Alan Palmer
|
|
2018
|
|
310,000
|
|
837,000
|
|
273,014
|
|
-
|
|
34,672
|
|
1,454,686
|
|
Executive Vice President and Chief Financial Officer
|
|
2017
|
|
307,692
|
|
360,000
|
|
-
|
|
-
|
|
24,168
|
|
691,860
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F. Julius Smith, III
|
|
2018
|
|
400,000
|
|
677,000
|
|
-
|
|
-
|
|
77,289
|
|
1,154,289
|
|
Senior Vice President
|
|
2017
|
|
396,250
|
|
565,000
|
|
-
|
|
412,062
|
|
22,042
|
|
1,395,354
|
|
(1)
|
The amounts in this column consist of the named executive officers’ respective cash bonus awards, which are awarded on a discretionary basis. In addition, for Mr. Smith, the amount shown includes $300,000 of cash retention payments made pursuant to his employment and non-competition agreement during each of the 2017 and 2018 fiscal years.
|
|
(2)
|
The amount in this column represents the grant date fair value of an award of 35,280 restricted shares of our Class B common stock to Mr. Palmer on February 23, 2018, of which 17,640 shares vested on the grant date and 17,640 shares vested on July 1, 2018, computed in accordance with Accounting Standards Codification Topic 718,
Compensation - Stock Compensation
(“ASC Topic 718”).
|
|
(3)
|
The amount in this column represents the grant date fair value of a non-plan option award granted to Mr. Smith on March 7, 2017 to purchase 74,592 shares of our Class B common stock at an exercise price of $0.04 per share, computed in accordance with ASC Topic 718 and excluding the effect of estimated forfeiture. For assumptions used in determining the fair value of option awards, see Note 15 (Equity-Based Compensation) to our consolidated financial statements included in our Annual Report. This option represents part of the consideration paid in the Company’s acquisition of FSC II, LLC (“FSC”).
|
|
(4)
|
The amounts in this column include the following items: (a) for each of the named executive officers, the value of his personal use of a Company-owned vehicle, 401(k) plan matching contributions, mobile device subscription fees paid on the officer’s behalf, and Company-paid premiums for health and life insurance; (b) for each of Messrs. Owens and Palmer, Company-paid premiums for long-term care benefits (2017 only) and long-term disability insurance; and (c) for Mr. Smith, Company-paid club dues. The value to the named executive officers of their personal use of Company-owned automobiles is based on the incremental cost to the Company of such use, which the Company has calculated as the total variable expense associated with operation of such automobiles during the applicable period.
|
|
Name
|
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
|
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
|
Charles E. Owens
|
|
-
|
|
-
|
|
-
|
|
-
|
|
R. Alan Palmer
|
|
-
|
|
-
|
|
-
|
|
-
|
|
F. Julius Smith, III
|
|
-
|
|
74,592
|
|
$0.04
|
|
March 7, 2027
(1)
|
|
(1)
|
Mr. Smith’s option was granted pursuant to a written option agreement, dated March 7, 2017, and may be exercised only on the occurrence of a change in control of the Company, as defined in the option agreement. The option expires on the earliest of (i) the termination of Mr. Smith’s services, whether as our employee, director or consultant, (ii) March 7, 2027, or (iii) the occurrence of a change in control of the Company, after which all unexercised options will be canceled. This option represents part of the consideration paid in the Company’s acquisition of FSC.
|
|
Plan Category
|
|
(a)
Number of Securities to be
Issued Upon Exercise of
Outstanding Options
and Rights
|
|
(b)
Weighted-Average Exercise Price of Outstanding Options and Rights
|
|
(c)
Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the First Column)
|
|
Equity Compensation Plans Approved by Security Holders
|
|
-
|
|
-
|
|
2,000,000
(2)
|
|
Equity Compensation Plans Not Approved by Security Holders
|
|
74,952
(1)
|
|
$0.04
|
|
-
|
|
Total
|
|
-
|
|
-
|
|
-
|
|
(1)
|
Represents shares of Class B common stock issuable pursuant to a non-plan option granted to Mr. Smith on March 7, 2017 that becomes exercisable only in the event of a change in control of the Company, as defined in the option agreement.
|
|
(2)
|
Represents shares of Class A common stock available for issuance under the 2018 Equity Plan, described above, under which no awards were issued or outstanding as of September 30, 2018.
|
|
Name
|
|
Fees Earned or Paid in Cash
($)
|
|
Total
($)
|
|
Ned N. Fleming, III
|
|
-
|
|
-
|
|
Craig Jennings
|
|
-
|
|
-
|
|
Mark R. Matteson
|
|
-
|
|
-
|
|
Michael H. McKay
|
|
60,000
|
|
60,000
|
|
Stefan L. Shaffer
|
|
-
|
|
-
|
|
David Webb
(1)
|
|
-
|
|
-
|
|
(1)
|
Mr. Webb resigned from his position as a member of our Board on November 15, 2017 and was replaced by independent Board member Stefan L. Shaffer.
|
|
•
|
whether the terms of the transaction are fair to the Company, have resulted from arm’s length negotiations and are on terms at least as favorable as would apply if the transaction did not involve a related party;
|
|
•
|
whether there are demonstrable business reasons for the Company to enter into the transaction;
|
|
•
|
whether the transaction is material to the Company;
|
|
•
|
the role the related party played in arranging the transaction;
|
|
•
|
whether the transaction could impair the independence of a director; and
|
|
•
|
the interests of all related parties in the transaction.
|
|
•
|
The Audit Committee has reviewed and discussed with management the Company’s audited consolidated financial statements as of, and for the fiscal year ended, September 30, 2018.
|
|
•
|
The Audit Committee has discussed with the Company’s independent registered public accountants, RSM, the matters required to be discussed by Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard No. 1301, Communications with Audit Committees (as amended), as well as all other matters required to be discussed with the independent auditors by applicable PCAOB standards.
|
|
•
|
The Audit Committee has received and reviewed the written disclosures and the letter from RSM required by applicable rules of the PCAOB regarding RSM’s communications with the Audit Committee concerning independence, and has discussed with RSM their independence.
|
|
|
Audit Committee:
|
|
|
|
|
|
Mark R. Matteson,
Chairperson
|
|
|
Michael H. McKay
|
|
|
Stefan L. Shaffer
|
|
Charles E. Owens
|
Ned N. Fleming, III
|
|
|
|
2018
|
|
|
2017
|
||
|
Audit Fees
|
|
$
|
1,942,249
|
|
|
$
|
1,075,266
|
|
Audit-Related Fees
|
|
|
0
|
|
|
|
0
|
|
Tax Fees
|
|
|
0
|
|
|
|
0
|
|
All Other Fees
|
|
|
0
|
|
|
|
0
|
|
TOTAL
|
|
$
|
1,942,249
|
|
|
$
|
1,075,266
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|